Upacicalcet (sodium), CAS [[2052969-18-1]]

Produktübersicht

• Artikelname: Upacicalcet (sodium), CAS [[2052969-18-1]]
• Artikelnummer: MCE-HY-109106A
• Hersteller Artikelnummer: HY-109106A
• Alternativnummer: MCE-HY-109106A-5MG,MCE-HY-109106A-10MMX1ML,MCE-HY-109106A-25MG,MCE-HY-109106A-50MG,MCE-HY-109106A-10MG,MCE-HY-109106A-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: SK-1403, AJT240, PLS240

Produktbeschreibung

Upacicalcet sodium is a non-peptide calcimimetic that acts as a CaSR agonist (EC50 = 10.8 nM). Upacicalcet sodium reduces serum intact parathyroid hormone (iPTH) and serum Ca2+ levels, reducing hypocalcemia and gastrointestinal complications. Upacicalcet sodium sodium improves vascular calcification and bone disorders in the Adenine (HY-B0152)-induced secondary hyperparathyroidism (SHPT) rat model. Upacicalcet sodium sodium inhibits cortical pore formation and reduces bone fibrosis in rats with chronic kidney disease (CKD). Upacicalcet sodium is useful for studying SHPT[1][2].

Produkteigenschaften

• Molekulargewicht: 373.75
• Reinheit: 99.91
• CAS Nummer: [2052969-18-1]
• Formel: C11H13ClN3NaO6S
• Target-Kategorie: CaSR

Anwendungsbeschreibung

• Anwendungsbeschreibung: Reference compound